Quantification of PPAR-γ protein in monocyte/macrophages from healthy smokers and non-smokers:: A possible direct effect of nicotine

被引:42
作者
Amoruso, Angela
Bardelli, Claudio
Gunella, Gabriele
Fresu, Luigia Grazia
Ferrero, Valeria
Brunelleschi, Sandra
机构
[1] Univ Piemonte Orientale Amedeo Avogadro, Sch Med, Dept Med Sci, I-28100 Novara, Italy
[2] Univ Verona, Osped Civile Maggiore, Div Cardiol, I-37100 Verona, Italy
[3] Univ Piemonte Orientale, IRCAD, I-28100 Novara, Italy
关键词
peroxisome proliferator-activated receptor-gamma; monocytes; monocyte-derived macrophages; tobacco smoke; nicotine tumour necrosis factor-alpha; interleukin-6; ciglitazone; PPAR-gamma ligands;
D O I
10.1016/j.lfs.2007.07.017
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Previous observations demonstrated that Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma), a key regulator of adipocyte differentiation, is expressed in a large variety of cells, including cells of the monocyte/macrophage lineage. This study was aimed to quantify both the constitutive and ligand-induced PPAR-gamma expression in monocytes and monocyte-derived macrophages (MDM) isolated from healthy smokers and non-smokers, and to evaluate the possible direct effect of nicotine. PPAR-gamma protein was detected by Western blot and quantification was performed by calculating the ratio between PPAR-gamma and beta-actin protein expression. Cytokine release was measured with enzyme-linked immunoassay kits. Constitutive PPAR-gamma protein was detected in human monocytes and its expression was up-regulated along with differentiation to MDM. The endogenous ligand 15-deoxy-delta(12.14)-prostaglandin J(2) and the synthetic agonist ciglitazone enhanced PPAR-gamma expression, the former being effective also at low micromolar concentrations. Both agonists significantly inhibited the basal secretion of pro-inflammatory cytokines (e.g., TNF-alpha, IL-6), ciglitazone being more potent. Monocytes and MDM from healthy smokers presented a significantly enhanced (4-fold and 2.5-fold, respectively) constitutive PPAR-gamma expression, as compared to those from healthy non-smokers. However, ligand-induced PPAR-gamma expression and inhibition of cytokine secretion were similar in healthy smokers and non-smokers. Nicotine dose-dependently enhanced PPAR-gamma expression with a maximum at 10 mu M, and inhibited release of pro-inflammatory cytokines; these effects were reversed by alpha-bungarotoxin. Nicotine and PPAR-gamma agonists did not exert synergistic effects. In conclusion, monocytes and MDM from healthy smokers present a constitutively enhanced PPAR-gamma expression; this effect is reproduced, to some extent, by nicotine in vitro. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:906 / 915
页数:10
相关论文
共 45 条
[11]   PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation [J].
Chawla, A ;
Barak, Y ;
Nagy, L ;
Liao, D ;
Tontonoz, P ;
Evans, RM .
NATURE MEDICINE, 2001, 7 (01) :48-52
[12]   Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages [J].
Chinetti, G ;
Griglio, S ;
Antonucci, M ;
Torra, IP ;
Delerive, P ;
Majd, Z ;
Fruchart, JC ;
Chapman, J ;
Najib, J ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) :25573-25580
[13]   Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? [J].
Conti-Fine, BM ;
Navaneetham, D ;
Lei, S ;
Maus, ADJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 393 (1-3) :279-294
[14]   Nicotine increases oxidative stress, activates NF-κB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate:: relevance to colon carcinogenesis [J].
Crowley-Weber, CL ;
Dvorakova, K ;
Crowley, C ;
Bernstein, H ;
Bernstein, C ;
Garewal, H ;
Payne, CM .
CHEMICO-BIOLOGICAL INTERACTIONS, 2003, 145 (01) :53-66
[15]   Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway [J].
de Jonge, WJ ;
van der Zanden, EP ;
O The, F ;
Bijlsma, MF ;
van Westerloo, DJ ;
Bennink, RJ ;
Berthoud, HR ;
Uematsu, S ;
Akira, S ;
van den Wijngaard, RM ;
Boeckxstaens, GE .
NATURE IMMUNOLOGY, 2005, 6 (08) :844-851
[16]   GM-CSF deficiency reduces macrophage PPAR-γ expression and aggravates atherosclerosis in ApoE-deficient mice [J].
Ditiatkovski, Michael ;
Toh, Ban-Hock ;
Bobik, Alex .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (10) :2337-2344
[17]   15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA [J].
FORMAN, BM ;
TONTONOZ, P ;
CHEN, J ;
BRUN, RP ;
SPIEGELMAN, BM ;
EVANS, RM .
CELL, 1995, 83 (05) :803-812
[18]   In vitro differentiation of human monocytes to macrophages: Change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors [J].
Gantner, F ;
Kupferschmidt, R ;
Schudt, C ;
Wendel, A ;
Hatzelmann, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (02) :221-231
[19]   Macrophage-stimulating protein differently affects human alveolar macrophages from smoker and non-smoker patients:: evaluation of respiratory burst, cytokine release and NF-κB pathway [J].
Gunella, Gabriele ;
Bardelli, Claudio ;
Amoruso, Angela ;
Viano, Ilario ;
Balbo, Piero ;
Brunelleschi, Sandra .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (04) :478-489
[20]   15-Deoxy-Δ12,14-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-γ-independent mechanism [J].
Hinz, B ;
Brune, K ;
Pahl, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 302 (02) :415-420